Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Residency Update

30 Jan 2018 07:00

RNS Number : 2599D
Phoenix Group Holdings
30 January 2018
 

Phoenix Group Holdings

LEI: 21380031B1D56JRCE375

Notice to PGH shareholders and to holders of outstanding debt securities regarding change in the head office and tax residence of Phoenix Group Holdings ("PGH")

Further to the announcement dated 21 June 2017, notice is hereby given that with effect from 31 January 2018 the central management and control, and the head office, of PGH will move from Jersey to the United Kingdom, with the intention that PGH will be resident in the United Kingdom for tax purposes from such date.

With effect from 31 January 2018, the PRA will treat PGH, and not Phoenix Life Holdings Limited ("PLHL"), as the ultimate EEA insurance holding company of the Insurance Group.

Holders of the subordinated securities:

· £428,113,000 6.625 per cent. Guaranteed Subordinated Notes due 2025;

· £450,000,000 4.125 per cent. Tier 3 Notes due 2022 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme; and

· U.S.$500,000,000 5.375 per cent. Notes due 2027 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme,

each issued by PGH (together, the "Outstanding Subordinated Securities"), are hereby notified that as such, PGH will become the ultimate EEA insurance holding company and the Insurance Group Parent Entity and a member of the Insurance Group for the purposes of the terms and conditions of the Outstanding Subordinated Securities. This will result in the Outstanding Subordinated Securities (and not the relevant on-loan of the proceeds of the Outstanding Subordinated Securities) being the only relevant capital item for the purposes of the definition of "Capital Disqualification Event" under the Outstanding Subordinated Securities with effect from such date.

PLHL will no longer be required by the PRA to be taken into account for the purposes of the deferral of principal and interest on the Outstanding Subordinated Securities pursuant to the definitions of "Regulatory Deficiency Interest Deferral Event" and "Regulatory Deficiency Redemption Deferral Event".

Capitalised terms that are not defined in this announcement will have the meanings given to them in the terms and conditions of the Outstanding Subordinated Securities.

The change in tax residency is not expected to impact PGH shareholders, other than UK stamp duty reserve tax (currently levied at 0.5%) will be incurred on subsequent purchases of PGH depositary interests.

Any PGH shareholder who is uncertain of the implications of the change in PGH's tax residency on their investment is recommended to obtain professional advice.

The change in tax residency will not impact the terms and conditions of the ÂŁ300,000,000 5.75 per cent. Bonds due 2021 (of which ÂŁ121,610,000 remains outstanding).

For further information, please contact:

 

Debt investors:

Rashmin Shah, Group Treasurer, Phoenix Group

Telephone: +44 (0) 20 3735 0059

Email: rashmin.shah@thephoenixgroup.com

 

Equity investors/analysts:Sam Perowne, Head of Investor Relations, Phoenix GroupTelephone: +44 (0) 20 3735 0021

Email: Samuel.Perowne@thephoenixgroup.com

 

 

Website: www.thephoenixgroup.com

 

This notice does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEDFWUFASEDF
Date   Source Headline
2nd May 201810:02 amRNSDirectorate Change
30th Apr 20184:15 pmRNSTotal Voting Rights
24th Apr 20183:45 pmRNSPublication of a Prospectus
19th Apr 201810:15 amRNSPre Stabilisation Notice
18th Apr 20184:34 pmRNSPublication of a Prospectus
13th Apr 20187:00 amRNSRestricted Tier 1 Roadshow Announcement
6th Apr 20184:00 pmRNSBlock listing Interim Review
6th Apr 20184:00 pmRNSDirector/PDMR Shareholding
29th Mar 20182:00 pmRNSTotal Voting Rights
27th Mar 20184:23 pmRNSNotice of AGM
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:10 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
21st Mar 20185:00 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAnnual Financial Report
7th Mar 201810:30 amRNSDirector/PDMR Shareholding
28th Feb 201811:00 amRNSTotal Voting Rights
27th Feb 20182:30 pmRNSHolding(s) in Company
23rd Feb 20187:01 amRNSAcquisition of Standard Life Assurance
12th Feb 20189:00 amRNSHolding(s) in Company
12th Feb 20189:00 amRNSDirector/PDMR Shareholding
31st Jan 201811:45 amRNSTotal Voting Rights
30th Jan 20187:00 amRNSResidency Update
29th Dec 20171:00 pmRNSHolding(s) in Company
29th Dec 20171:00 pmRNSTotal Voting Rights
19th Dec 20175:00 pmRNSHolding(s) in Company
6th Dec 20174:30 pmRNSDirector/PDMR Shareholding
4th Dec 20174:00 pmRNSDirector Declaration
30th Nov 20174:00 pmRNSTotal Voting Rights
28th Nov 20174:30 pmRNSHolding(s) in Company
8th Nov 20175:20 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:45 pmRNSHolding(s) in Company
31st Oct 20173:00 pmRNSTotal Voting Rights
27th Oct 20174:30 pmRNSHolding(s) in Company
27th Oct 20174:30 pmRNSHolding(s) in Company
20th Oct 20174:30 pmRNSHolding(s) in Company
18th Oct 20174:45 pmRNSHolding(s) in Company
16th Oct 20174:30 pmRNSHolding(s) in Company
13th Oct 20174:15 pmRNSHolding(s) in Company
9th Oct 20174:00 pmRNSBlock listing Interim Review
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
4th Oct 20174:45 pmRNSDirector/PDMR Shareholding
29th Sep 20173:00 pmRNSTotal Voting Rights
13th Sep 20174:30 pmRNSPublication of Suppl.Prospcts
12th Sep 20179:15 amRNSHolding(s) in Company
12th Sep 20179:15 amRNSHolding(s) in Company
7th Sep 20173:30 pmRNSDirector/PDMR Shareholding
31st Aug 20174:45 pmRNSHolding(s) in Company
31st Aug 20174:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNS2017 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.